Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PAK-01 enhances reperfusion and neuroprotection with no hemorrhagic transformation in vivo

Feb. 20, 2014

Preclinical results presented for RTL-1000 as a therapeutic agent for stroke

Feb. 20, 2014

DNA hypermethylation associated with shortened PFS in patients with RCC

Feb. 19, 2014

CNB-001 demonstrates promising neuroprotective activity in vivo

Feb. 19, 2014

Zenith Epigenetics identifies new compounds for epigenetics drug discovery

Feb. 19, 2014

AXIN2 gene as a potential new biomarker for prostate cancer recurrence

Feb. 18, 2014

Biomarker-driven development of resminostat

Feb. 18, 2014

GSK researchers present data on novel LSD1 inhibitors

Feb. 18, 2014

EpiTherapeutics prepares and tests novel KDM5 inhibitors

Feb. 17, 2014

Results presented from phase I study of ridaforolimus and vorinostat in RCC

Feb. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...